Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · Real-Time Price · USD
26.14
-0.06 (-0.23%)
At close: Oct 14, 2025, 4:00 PM EDT
26.11
-0.03 (-0.11%)
After-hours: Oct 14, 2025, 6:24 PM EDT

Travere Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
2,3301,5166761,3501,9001,391
Upgrade
Market Cap Growth
102.55%124.43%-49.94%-28.99%36.59%128.10%
Upgrade
Enterprise Value
2,4101,6414461,2511,6091,177
Upgrade
Last Close Price
26.1417.428.9921.0331.0427.25
Upgrade
PS Ratio
6.626.504.6512.3314.427.02
Upgrade
PB Ratio
71.1325.663.3631.496.296.59
Upgrade
P/TBV Ratio
--7.01-12.3724.37
Upgrade
EV/Sales Ratio
7.227.043.0711.4312.215.93
Upgrade
Debt / Equity Ratio
12.206.802.029.510.871.16
Upgrade
Asset Turnover
0.600.340.200.150.190.33
Upgrade
Inventory Turnover
43.7928.8636.8139.1627.4820.15
Upgrade
Quick Ratio
1.901.993.333.304.594.26
Upgrade
Current Ratio
2.002.083.473.424.704.43
Upgrade
Return on Equity (ROE)
-705.73%-246.75%-308.90%-192.18%-84.66%-78.37%
Upgrade
Return on Assets (ROA)
-19.28%-23.15%-32.22%-27.58%-18.01%-7.77%
Upgrade
Return on Capital (ROIC)
-25.08%-30.03%-44.60%-39.41%-24.45%-10.69%
Upgrade
Earnings Yield
-7.26%-21.21%-16.49%-20.64%-9.48%-12.18%
Upgrade
FCF Yield
-4.96%-15.66%-41.45%-13.80%-1.05%-3.56%
Upgrade
Buyback Yield / Dilution
-10.00%-6.22%-16.48%-6.56%-25.86%-12.28%
Upgrade
Updated May 1, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q